-
Acknowledgements: Clinical Investigation Vol 3, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 11
Acknowledgements: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation
-
Antibiotics in irritable bowel yndrome: a novel approach to a challenging disorder
Eamonn MM Quigley
Editorial: Clinical Investigation